New Studies By Cognition Therapeutics Researchers Reveal COGRX’s Memory Restoration Benefits

New Studies By Cognition Therapeutics Researchers Reveal COGRX’s Memory Restoration Benefits
Cognition Therapeutics Inc. announced the discovery of a new drug target in the brain that plays a role in the development of Alzheimer’s disease, and their investigation of new drug candidates to reverse the memory loss associated with Alzheimer’s. The two studies were entitled “Alzheimer’s therapeutics targeting Amyloid beta 1-42 oligomers I: Abeta oligomers binding to specific neuronal

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *